查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1830969

电疗系统市场

Electrotherapy Systems Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

2024 年电疗系统市场价值约 49.9 亿美元，预计到 2031 年将成长至约 94.2 亿美元。预计 2025 年至 2031 年期间市场复合年增长率为 8.1%。市场洞察与分析师观点：本报告概述了基于电疗系统市场当前趋势的成长机会及其在预测期内的预期影响。

电疗系统是一种医疗设备，旨在透过向患者组织输送电流来增强其肌肉功能。电疗可有效缓解急性创伤后和术后疼痛，促进伤口癒合，缓解肌肉痉挛，预防和缓解废用性萎缩，辅助肌肉康復，维持和增强活动范围，以及缓解急性创伤后和术后疼痛。通常，电疗装置由一个电池供电的设备连接到粘附在皮肤上的黏性电极片组成。运动伤害发生率的上升以及製造商的策略性倡议等因素正在推动电疗系统市场的成长。

市场驱动因素：癌症、心血管疾病、神经血管疾病和肌肉骨骼疾病等慢性疾病的日益普及预计将推动疼痛管理设备市场的成长。这些疾病会削弱免疫力并引起慢性疼痛，严重影响个人健康。慢性病最常见于成年人和老年族群。例如，美国疾病管制与预防中心的资料显示，2019 年至 2021 年间，美国成年人慢性疼痛的盛行率为 20.5% 至 21.8%，其中高强度慢性疼痛的盛行率为 6.9% 至 7.8%。 2021 年，约有 5,160 万美国成年人患有慢性疼痛，其中 1,710 万人面临高强度慢性疼痛。

此外，慢性疼痛在运动员、运动爱好者和曾经受伤的人群中普遍存在。慢性疼痛会增加人们在日常活动中对他人的依赖，因此疼痛管理对于维持正常生活至关重要。电疗系统能够提供持久的缓解，并有助于改善健康状况，从而推动电疗系统市场的成长。

根据2022年7月发布的《脊髓损伤事实与统计》报告，每年约有17,700名美国人遭受脊髓损伤，其中约78%为男性，平均年龄为43岁。美国国家安全委员会的估计表明，2021年美国有近320万人因与运动和娱乐设备相关的伤害到急诊室就诊。因此，高脊髓损伤率支持了电疗系统市场的成长。

《联邦食品、药品和化妆品法案》将电肌肉刺激器 (EMS) 归类为设备。 FDA 根据立法和该机构的指南监管美国所有电肌肉刺激器的销售。因此，除非公司遵守所有相关的 FDA 上市前监管要求，否则它们不能合法销售其刺激器。 FDA 评估的大多数电肌肉刺激器旨在在医生的监督下用于物理治疗和復健。如果公司希望将 EMS 设备直接销售给消费者，则必须向 FDA 证明其 EMS 设备可以安全有效地用于该环境。销售 EMS 设备的公司必须遵守适用的 FDA 上市前监管标准，然后才能合法销售其产品。因此，对电疗产品的严格监管要求可能会阻碍电疗系统市场的成长。

策略洞察报告细分和范围：透过检查以下细分市场来分析电疗系统市场：产品、应用和最终用户。

分段分析：电疗系统市场按产品细分为经皮神经电刺激 (PENS)、经皮神经电刺激 (TENS)、脊髓刺激 (SCS)、微电流疗法、干扰电流疗法 (IC)、电针 (EA)、脉衝短波透热疗法 (PSWD)、经皮脊髓电镇痛 (TSE) 等。脊髓刺激细分市场在 2022 年占据最大市场份额，预计在 2022 年至 2030 年期间将达到最高复合年增长率。脊髓刺激已在医疗机构中使用多年。颈椎和腰椎神经根炎、背部手术失败症候群、复杂性区域疼痛症候群和神经病变等疾病可从此疗法中受益。脊髓刺激是一种有效、安全且经济高效的慢性疼痛治疗​​方法。较新的脊髓刺激技术正在开发中，以解决更广泛的临床适应症，包括内臟疼痛和缺血性疼痛，并有可能提高疗效。

根据应用，市场分为神经肌肉功能障碍、疼痛管理、急性和慢性水肿、运动伤害治疗、离子电渗透疗法、失禁等。疼痛管理部分在 2022 年占据了电疗系统市场的最大份额，预计在 2022 年至 2030 年期间将呈现最高的复合年增长率。这一领域的成长是由创伤和运动伤害日益普遍所驱动的。根据世界卫生组织 2022 年 3 月发布的资料，近 3,000 万名儿童和青少年参与有组织的运动，导致每年报告的伤害超过 350 万起。此外，据估计，2021 年美国有 57 万人经历过创伤性疼痛。背痛和颈痛的增加也导致电疗治疗慢性疼痛的需求不断增加。

按最终用户划分，电疗系统市场分为医院、诊所、长期护理机构、復健中心和其他。 2022年，医院占据了电疗系统市场的最大份额。

区域分析：电疗系统市场报告涵盖北美（美国、加拿大和墨西哥）、欧洲（西班牙、英国、德国、法国、义大利和欧洲其他地区）、亚太地区（韩国、中国、印度、日本、澳洲和亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋和中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和其他地区）。就收入而言，北美在 2022 年引领了电疗系统市场。人口老化是该地区对电疗需求增加的重要因素。根据世界卫生组织 2022 年 12 月发布的资料，估计到 2053 年，北美将有 7,300 万人年龄在 65 岁或以上。同一来源还表明，17% 的 65 岁以上的美国人口患有背痛和脊椎损伤。

电疗系统市场报告范围、竞争格局和主要公司：本电疗系统市场报告重点关注行业主要参与者，包括BTL、DJO LLC、欧姆龙医疗保健公司、雅培、波士顿科学公司、美敦力、Nevro Corp、Phoenix Healthcare、Eme srl和Pure Care。这些公司致力于开发新技术、改进现有产品并扩大市场份额，以满足日益增长的全球消费者需求。电疗系统市场预测可以帮助利害关係人规划其成长策略。

2022年1月，全球领先的医疗科技公司美敦力公司（Medtronic plc）获得美国食品药物管理局（FDA）批准其Intellis（可充电）和Vanta（免充电）神经刺激器用于治疗糖尿病週边神经病变（DPN）相关的慢性疼痛。这项新适应症使DPN患者能够使用美敦力领先的SCS产品组合，该组合包括多种个人化治疗编程选项、不受限制的MRI访问、卓越的电池化学成分和性能，以及美敦力TYRX Neuro可吸收抗菌包膜。 2021年3月，FDA批准了美敦力公司针对其具有差异靶点多路復用（DTM）编程功能的Intellis平台提交的修订商业标籤申请。新的标籤包含了一项多中心随机对照试验的研究结果，强调了DTM SCS相比传统SCS在缓解背痛方面更佳的疗效。 2020年9月，波士顿科学公司（Boston Scientific）在欧洲推出了WaveWriter Alpha系列SCS系统。该产品组合包含四款支援蓝牙的MRI条件式植入式脉衝产生器 (IPG)，可根据患者需求提供更个人化的客製化服务。这些产品提供可充电和不可充电两种选择，并支援针对多个疼痛区域的波形。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：电疗系统市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：电疗系统市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：电疗系统市场-全球市场分析

  • 电疗系统 - 全球市场概览
  • 电疗系统－全球市场及2030年预测

第七章：电疗系统市场-收入分析-依产品，2020-2030

  • 概述
  • 经皮神经电刺激（PENS）
  • 脊髓刺激（SCS）
  • 经皮神经电刺激（TENS）
  • 微电流疗法
  • 干扰电流疗法（IC）
  • 电针疗法（EA）
  • 脉衝短波透热疗法（PSWD）
  • 经皮脊髓电镇痛（TSE）
  • 其他的

第 8 章：电疗系统市场 - 收入分析 - 按应用，2020-2030 年

  • 概述
  • 神经肌肉功能障碍
  • 疼痛管理
  • 急性和慢性水肿
  • 运动伤害治疗
  • 组织修復
  • 离子电渗透疗法
  • 尿失禁和大便失禁
  • 其他的

第 9 章：电疗系统市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院
  • 诊所
  • 復健中心
  • 长期照护中心
  • 其他的

第 10 章：电疗系统市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 13 章：电疗系统市场 - 主要公司简介

  • BTL Industries LLC
  • DJO, LLC
  • Omron Healthcare, Inc.
  • Medtronic plc
  • Boston Scientific Corporation
  • Nevro Corporation
  • Abbott
  • EME srl
  • Phoenix Healthcare
  • Pure Care

第 14 章：附录

简介目录
Product Code: TIPHE100001378

The electrotherapy systems market was valued at approximately US$ 4.99 billion in 2024 and is projected to grow to around US$ 9.42 billion by 2031. The market is anticipated to experience a CAGR of 8.1% from 2025 to 2031.Market Insights and Analyst Perspective:This report outlines growth opportunities based on current trends in the electrotherapy systems market and their expected effects during the forecast period.

An electrotherapy system is a medical device designed to enhance a patient's muscle function by delivering electric currents through their tissues. Electrotherapy is effective in managing acute post-traumatic and post-surgical pain, promoting wound healing, relaxing muscle spasms, preventing and alleviating disuse atrophy, assisting in muscle rehabilitation, maintaining and enhancing range of motion, and alleviating acute post-traumatic and post-surgical pain. Typically, electrotherapy units consist of a battery-operated device connected to adhesive electrode pads that adhere to the skin. Factors such as the rising incidence of sports injuries and strategic initiatives by manufacturers are driving the growth of the electrotherapy systems market.

Market Drivers:The increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, neurovascular diseases, and musculoskeletal disorders, is expected to fuel the growth of the pain management devices market. These conditions significantly impact an individual's health by weakening immunity and causing chronic pain. Chronic diseases are most frequently observed in adults and the elderly population. For example, data from the Centers for Disease Control and Prevention indicates that between 2019 and 2021, the prevalence of chronic pain among US adults ranged from 20.5% to 21.8%, with high-impact chronic pain affecting 6.9% to 7.8%. In 2021, approximately 51.6 million US adults experienced chronic pain, and 17.1 million faced high-impact chronic pain.

Moreover, chronic pain is often prevalent among athletes, sports enthusiasts, and individuals with previous injuries. The occurrence of chronic pain increases a person's reliance on others for daily activities, making pain management crucial for maintaining a normal routine. Electrotherapy systems offer prolonged relief and contribute to improved health, thus driving the growth of the electrotherapy systems market.

According to the report "Spinal Cord Injury Facts and Stats" published in July 2022, approximately 17,700 Americans sustain a spinal cord injury each year, with around 78% being men and an average age of 43. Estimates from the National Safety Council indicate that nearly 3.2 million individuals in the US sought treatment in emergency departments for injuries related to sports and recreational equipment in 2021. Consequently, the high rate of spinal cord injuries supports the growth of the electrotherapy systems market.

The Federal Food, Drug, and Cosmetic Act categorizes electrical muscle stimulators (EMS) as devices. The FDA regulates the sale of all electrical muscle stimulators in the US according to the legislation and the agency's guidelines. Therefore, companies cannot legally sell their stimulators unless they comply with all relevant FDA premarket regulatory requirements. Most electrical muscle stimulators evaluated by the FDA are intended for use in physical therapy and rehabilitation under a physician's supervision. Companies must demonstrate to the FDA that their EMS devices can be safely and effectively used in that context if they wish to sell them directly to consumers. Companies marketing EMS devices must adhere to the applicable FDA premarket regulatory standards before they can legally sell their products. Thus, stringent regulatory requirements for electrotherapy products can hinder the growth of the electrotherapy systems market.

Strategic Insights

Report Segmentation and Scope:The analysis of the electrotherapy systems market has been conducted by examining the following segments: product, application, and end user.

Segmental Analysis:The electrotherapy systems market is segmented by product into percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation (SCS), micro-current therapy, interferential current therapy (IC), electro-acupuncture (EA), pulsed short wave diathermy (PSWD), transcutaneous spinal electroanalgesia (TSE), and others. The spinal cord stimulation segment held the largest market share in 2022 and is expected to register the highest CAGR from 2022 to 2030. Spinal cord stimulation has been utilized in medical facilities for many years. Conditions such as cervical and lumbar radiculitis, failed back surgery syndrome, complex regional pain syndrome, and neuropathy can benefit from this therapy. Spinal cord stimulation is an effective, safe, and cost-efficient method for managing chronic pain. Newer spinal cord stimulation technologies are being developed to address a broader range of clinical indications, including visceral and ischemic pain, with the potential for enhanced efficacy.

By application, the market is divided into neuromuscular dysfunction, pain management, acute and chronic edema, sports injury treatment, iontophoresis, urinary and fecal incontinence, and others. The pain management segment accounted for the largest share of the electrotherapy systems market in 2022 and is projected to exhibit the highest CAGR from 2022 to 2030. The growth of this segment is driven by the increasing prevalence of trauma and sports injuries. According to data from the World Health Organization released in March 2022, nearly 30 million children and teenagers participate in organized sports, resulting in over 3.5 million reported injuries annually. Additionally, it was estimated that 570,000 individuals experienced traumatic pain in the US in 2021. An increase in back pain and neck pain also contributes to the rising demand for electrotherapy to manage chronic pain.

By end user, the electrotherapy systems market is categorized into hospitals, clinics, long-term care facilities, rehabilitation centers, and others. In 2022, the hospitals segment represented the largest share of the electrotherapy systems market.

Regional Analysis:The electrotherapy systems market report encompasses North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, UAE, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In terms of revenue, North America led the electrotherapy systems market in 2022. The aging population is a significant factor contributing to the increased demand for electrotherapy in the region. According to WHO data released in December 2022, it is estimated that by 2053, 73 million individuals in North America will be aged 65 or older. The same source indicates that 17% of the US population over 65 years old experiences back pain and spinal injuries.

Electrotherapy Systems Market Report Scope

Competitive Landscape and Key Companies:The electrotherapy systems market report focuses on key players in the industry, including BTL, DJO LLC, Omron Healthcare Inc, Abbott, Boston Scientific Corporation, Medtronic, Nevro Corp, Phoenix Healthcare, Eme srl, and Pure Care. These companies are dedicated to developing new technologies, enhancing existing products, and expanding their market presence to meet the growing global consumer demand. The electrotherapy systems market forecast can assist stakeholders in planning their growth strategies.

In January 2022, Medtronic plc, a global leader in healthcare technology, received FDA approval for its Intellis (rechargeable) and Vanta (recharge-free) neurostimulators for treating chronic pain associated with diabetic peripheral neuropathy (DPN). This new indication provides DPN patients access to Medtronic's leading SCS portfolio, which includes multiple programming options for personalized therapy, unrestricted MRI access, and superior battery chemistry and performance, along with the Medtronic TYRX Neuro Absorbable Antibacterial Envelope.

In March 2021, the FDA approved Medtronic plc's application for revised commercial labeling for its Intellis platform with Differential Target Multiplexed (DTM) programming. The new labeling included study outcomes from a multicenter randomized control trial, highlighting superior back pain relief provided by DTM SCS compared to conventional SCS.

In September 2020, Boston Scientific launched the WaveWriter Alpha portfolio of SCS systems in Europe. This portfolio includes four MRI conditional, Bluetooth-enabled implantable pulse generators (IPGs) that offer greater personalization based on patient needs. The products feature both rechargeable and non-rechargeable options, as well as access to waveforms that address multiple pain areas.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Electrotherapy System Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Electrotherapy System Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Electrotherapy System Market - Global Market Analysis

  • 6.1 Electrotherapy System - Global Market Overview
  • 6.2 Electrotherapy System - Global Market and Forecast to 2030

7. Electrotherapy System Market - Revenue Analysis (USD Million) - By Product, 2020-2030

  • 7.1 Overview
  • 7.2 Percutaneous Electrical Nerve Stimulation (PENS)
  • 7.3 Spinal Cord Stimulation (SCS)
  • 7.4 Transcutaneous Electrical Nerve Stimulation (TENS)
  • 7.5 Micro-Current Therapy
  • 7.6 Interferential Current Therapy (IC)
  • 7.7 Electro-Acupuncture (EA)
  • 7.8 Pulsed Short Wave Diathermy (PSWD)
  • 7.9 Transcutaneous Spinal Electroanalgesia (TSE)
  • 7.10 Others

8. Electrotherapy System Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Neuromuscular Dysfunction
  • 8.3 Pain Management
  • 8.4 Acute and Chronic Edema
  • 8.5 Sports Injury Treatment
  • 8.6 Tissue Repair
  • 8.7 Iontophoresis
  • 8.8 Urine and Fecal Incontinence
  • 8.9 Others

9. Electrotherapy System Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Rehabilitation Centers
  • 9.5 Long Term Care Centers
  • 9.6 Others

10. Electrotherapy System Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Electrotherapy System Market Overview
    • 10.1.2 North America Electrotherapy System Market Revenue and Forecasts to 2030
    • 10.1.3 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By Product
    • 10.1.4 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By Application
    • 10.1.5 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Electrotherapy System Market
        • 10.1.6.1.1 United States Electrotherapy System Market, by Product
        • 10.1.6.1.2 United States Electrotherapy System Market, by Application
        • 10.1.6.1.3 United States Electrotherapy System Market, by End User
      • 10.1.6.2 Canada Electrotherapy System Market
        • 10.1.6.2.1 Canada Electrotherapy System Market, by Product
        • 10.1.6.2.2 Canada Electrotherapy System Market, by Application
        • 10.1.6.2.3 Canada Electrotherapy System Market, by End User
      • 10.1.6.3 Mexico Electrotherapy System Market
        • 10.1.6.3.1 Mexico Electrotherapy System Market, by Product
        • 10.1.6.3.2 Mexico Electrotherapy System Market, by Application
        • 10.1.6.3.3 Mexico Electrotherapy System Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Electrotherapy System Market - Key Company Profiles

  • 13.1 BTL Industries LLC
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 DJO, LLC
  • 13.3 Omron Healthcare, Inc.
  • 13.4 Medtronic plc
  • 13.5 Boston Scientific Corporation
  • 13.6 Nevro Corporation
  • 13.7 Abbott
  • 13.8 EME srl
  • 13.9 Phoenix Healthcare
  • 13.10 Pure Care

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud